Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD<sup>+</sup> Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.

Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, Cartwright DM, Oakey L, Burley CV, Jenkinson N, Wilson M, Lucas SJE, Akerman I, Seabright A, Lai YC, Tennant DA, Nightingale P, Wallis GA, Manolopoulos KN, Brenner C, Philp A, Lavery GG. · 2019

Read Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD<sup>+</sup> Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. by Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, Cartwright DM, Oakey L, Burley CV, Jenkinson N, Wilson M, Lucas SJE, Akerman I, Seabright A, Lai YC, Tennant DA, Nightingale P, Wallis GA, Manolopoulos KN, Brenner C, Philp A, Lavery GG. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6702140.txt.

Description

Elhassan and co-authors test nicotinamide riboside in aged human skeletal muscle. Their trial report appears in Cell Reports. NAD+ reportedly declines with ageing in animals. Human data had stayed sparse until now. Twelve men aged 70 to 80 enrolled. They took one gram daily for 21 days. The design was randomised, double-blind, and crossover. Targeted tests measured the muscle NAD+ pool. RNA sequencing profiled gene expression changes.

The supplement raised the muscle NAD+ metabolome clearly. Clearance products and kin metabolites increased. Energy pathways were dialled down at the RNA level. Mitochondrial output itself did not change. Blood inflammatory cytokines fell with treatment. The authors show the dose reaches aged muscle. Anti-inflammatory signatures are the novel finding.

Catalog record

CREATORElhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, Cartwright DM, Oakey L, Burley CV, Jenkinson N, Wilson M, Lucas SJE, Akerman I, Seabright A, Lai YC, Tennant DA, Nightingale P, Wallis GA, Manolopoulos KN, Brenner C, Philp A, Lavery GG.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE74 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6702140

Browse the full library · About the Tower of Babel